MedTrace Logo

The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes

NCT04879251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-12-07

No results posted yet for this study

Summary

The objective of this study is to compare cardiovascular risk factors in patients with diabetes before the start of the pandemic of the COVID 19 (time 1 - T1), after 1 year (time 2 - T2) and 2 years (time 3 - T3) duration. In patients with all types of diabetes, the investigators will compare the value of blood pressure, LDL cholesterol, BMI (body mass index) and glycated haemoglobin in T1, T2 and T3 during outpatient control.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jan Vaclavik · University Hospital Ostrava

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-26
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04879251 on ClinicalTrials.gov